Sepp hochreiter director, institute for machine learning, johannes kepler university linz, austria;

Ursula schmidt-erfurth. Medical university of vienna austria. Her scientific research focuses on the development of novel diagnostic techniques, e.g., retinal imaging and novel treatment strategies such as intravitreal pharmacotherapy. This is a platform for digital analysis in retinal imaging, which is linked to 600 centers.

2 christian doppler laboratory for ophthalmic image analysis,. The biggest influence on my consecutive research activity was my stay at harvard. Her clinical activities include surgical and medical retina.

Just click the edit page button at the bottom of the page or learn more in the biography submission guide. Obtaining models that capture imaging markers relevant for disease progression and treatment monitoring is challenging. I am delighted to offer you my specialist expertise in a personal consultation and professional environment.

Potential imaging biomarkers in the development and progression of diabetic retinopathy. In 2006, she set up the vienna reading center (vrc) at meduni vienna. Diabetic retinopathy (dr) is the most prevalent microvascular complication of diabetes and a leading cause of preventable.

Three‐year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: She has founded the vienna study center (vsc) which serves as. Models are typically based on.

A computerized device (100) for processing image data is proposed. Investigation of efficacy and safety in. As medical therapy for amd and other retinal diseases has entered a new era, so too have the imaging techniques used to diagnose retinal problems and monitor disease progression and treatment response.